Mesirow Financial Investment Management, Inc. Astrazeneca PLC Transaction History
Mesirow Financial Investment Management, Inc.
- $4.84 Billion
- Q2 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 8,335 shares of AZN stock, worth $686,303. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,335
Previous 11,033
24.45%
Holding current value
$686,303
Previous $810,000
28.15%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,451Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...